Pharmacological and Nonpharmacological Factors That Contribute Blood Pressure Control

Sponsor

Maltepe University (Other)

Overall Status

Completed

CT.gov ID

NCT05513430

Collaborator

Istanbul University (Other)

176

Enrollment

5.5

Actual Duration (Months)

Study Details

Study Description

Brief Summary

Study is an observational study among hypertensive patients

Condition or Disease	Intervention/Treatment	Phase
Hypertension,Essential

Detailed Description

Objective: To investigate drug adherence and lifestyle behaviors affecting the blood pressure (BP) control among hypertensive patients that have uncontrolled and controlled BP.

Study Design

Study Type:

Observational

Actual Enrollment :

176 participants

Observational Model:

Case-Control

Time Perspective:

Cross-Sectional

Official Title:

Pharmacological and Nonpharmacological Factors That Contribute Blood Pressure Control

Actual Study Start Date :

Jun 16, 2014

Actual Primary Completion Date :

Nov 30, 2014

Actual Study Completion Date :

Nov 30, 2014

Arms and Interventions

Arm	Intervention/Treatment
controlled hypertension Controlled hypertension was defined as systolic blood pressure (SBP) ≤139 mmHg and/or diastolic blood pressure (DBP)≤89 mmHg for non-diabetic patients, and as SBP ≤139 mmHg and/or DBP ≤84 mmHg for diabetic patients, based on the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) guidelines. observational study
uncontrolled hypertensive patients. Individuals who had blood pressure levels above these values were defined as uncontrolled hypertensive patients.

Outcome Measures

Primary Outcome Measures

health related quality of life. [at the time of the beginning of the study]
EQ-5D-3L turkish validation test
Age [at the time of the beginning of the study]
years
Gender [at the time of the beginning of the study]
Female/Male
BMI [at the time of the beginning of the study]
(kg/m2)

Secondary Outcome Measures

complementary and alternative medicine use [at the time of the beginning of the study]
subjective reports from patients (yes/no)

Eligibility Criteria

Criteria

Ages Eligible for Study:

N/A to 74 Years

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Patient inclusion criteria were as follows:

aged between 38 and 74 years,
hypertension diagnosis history of at least 6 months
use of at least one antihypertensive medication.

Exclusion Criteria:

-not willing to join the clinical trial

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

Maltepe University
Istanbul University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F; Task Force Members. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013 Jul;31(7):1281-357. doi: 10.1097/01.hjh.0000431740.32696.cc.

Responsible Party:

Asst. Prof. Zeynep Gunes Ozunal, M.D., Asst Prof, Maltepe University

ClinicalTrials.gov Identifier:

NCT05513430

Other Study ID Numbers:

000001

First Posted:

Aug 24, 2022

Last Update Posted:

Aug 24, 2022

Last Verified:

Aug 1, 2022

Individual Participant Data (IPD) Sharing Statement:

Plan to Share IPD:

Additional relevant MeSH terms:

Essential Hypertension

Study Results

No Results Posted as of Aug 24, 2022